Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain 4Prostatic Neoplasms 3Carcinoma, Hepatocellular 3Pain, Postoperative 2Lung Neoplasms 2Inflammation 2Stomach Neoplasms 1Postoperative Nausea and Vomiting 1Pancreatic Neoplasms 1Neuroma, Acoustic 1Neoplasms 1Melanoma 1Liver Neoplasms 1Liver Diseases 1Gynecological Laparoscopic Surgery 1Esophageal Neoplasms 1Emergence Delirium 1Chronic Pain 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Sufentanil × Clear all
NCT04248179 2023-02-09

The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.

Zealand University Hospital

Phase 4 Completed
36 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡